Kurzporträt
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Wendy Guy
FOU | Founder | 59 | 29.03.11 |
Sian Bigora
FOU | Founder | 63 | 29.03.11 |
David Young
FOU | Founder | 71 | 29.03.11 |
Patrick Lin
FOU | Founder | 58 | 29.03.11 |
George Ng
CEO | Chief Executive Officer | 49 | 08.08.23 |
Jim Stanker
DFI | Director of Finance/CFO | 67 | 05.09.18 |
Weifei Ye
CTO | Chief Tech/Sci/R&D Officer | - | - |
Kayla Parks
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | - | - | |
Mary Nyberg
PRN | Corporate Officer/Principal | - | - |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
George Ng
CEO | Chief Executive Officer | 49 | 08.08.23 |
James Neal
BRD | Director/Board Member | 68 | 16.07.22 |
Justin Yorke
CHM | Chairman | 58 | 02.10.17 |
Patrick Lin
FOU | Founder | 58 | 29.03.11 |
David Young
FOU | Founder | 71 | 29.03.11 |
Director/Board Member | 66 | 11.07.22 | |
Geraldine Pannu
BRD | Director/Board Member | 54 | 13.02.20 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 2 863 007 | 2 512 049 ( 87,74 %) | 5 000 ( 0,1746 %) | 87,74 % |
Unternehmenskontakt
Processa Pharmaceuticals, Inc.
7380 Coca Cola Drive Suite 106
21076, Hanover
+
http://www.processapharma.comSektor
% 1. Jan. | Kap. | |
---|---|---|
+51.54% | 781 Mrd. | |
-7.20% | 350 Mrd. | |
+18.67% | 330 Mrd. | |
+7.48% | 293 Mrd. | |
+16.91% | 248 Mrd. | |
+0.53% | 221 Mrd. | |
+11.06% | 217 Mrd. | |
+3.64% | 162 Mrd. | |
-3.96% | 157 Mrd. |